Berlin, Germany

Ursula Bojic

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ursula Bojic. Retrieved from https://idiyas.com/inventor/ursula-bojic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ursula Bojic: Innovator in Antiepileptic Compounds

Introduction

Ursula Bojic is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiepileptic compounds. Her innovative work focuses on creating effective treatments with minimal side effects.

Latest Patents

Ursula Bojic holds 1 patent for her invention titled "VPA-analogous antiepileptics." This invention provides compounds that are effective as antiepileptics while exhibiting only slight sedative and teratogenic effects. The compounds are characterized by a specific formula, where various radicals can be hydrogen or C1-C6 alkyl groups, ensuring a range of effective treatments.

Career Highlights

Throughout her career, Ursula has demonstrated a commitment to advancing medical science. Her research has led to the development of compounds that not only treat epilepsy but also minimize adverse effects, showcasing her dedication to patient safety and efficacy in treatment.

Collaborations

Ursula has collaborated with esteemed colleagues such as Heinz Nau and Ralf-Siegbert Hauck. These partnerships have enriched her research and contributed to the successful development of her patented compounds.

Conclusion

Ursula Bojic's innovative work in the field of antiepileptic compounds highlights her role as a significant contributor to medical advancements. Her dedication to creating effective treatments with reduced side effects is commendable and reflects her commitment to improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…